Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells
Sanford P. C. Hsu(National Yang Ming Chiao Tung University), Kwan-Hwa Chi(Albert Einstein College of Medicine)
Cited by 43
Related Papers
Prognosis of Esophageal Squamous Cell Carcinoma: Analysis of Clinicopathological and Biological Factors
|The American Journal of Gastroenterology|1999|101